Point72 (DIFC)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-800
Closed -$336K 1823
2025
Q1
$336K Buy
800
+500
+167% +$217K 0.01% 746
2024
Q4
$124K Sell
300
-900
-75% -$395K ﹤0.01% 961
2024
Q3
$606K Buy
1,200
+500
+71% +$243K 0.02% 602
2024
Q2
$341K Sell
700
-600
-46% -$301K 0.01% 744
2024
Q1
$702K Buy
+1,300
New +$710K 0.02% 655

Other funds holding IDXX

Point72 (DIFC)'s IDXX Position: Q2 2024 in Review

Point72 (DIFC) sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 7,275 shares — an estimated $3.65M sold.

Point72 (DIFC) first reported a position in IDXX in Q1 2024 and held it in 1 quarter. The position peaked at $3.93M in Q1 2024. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Point72 (DIFC) reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Point72 (DIFC) sold 7,275 Idexx Laboratories shares in Q2 2024, an estimated $3.65M.
  • Point72 (DIFC) first reported a position in Idexx Laboratories in Q1 2024 and held it in 1 quarter.
  • Point72 (DIFC)'s Idexx Laboratories position peaked at $3.93M in Q1 2024.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Point72 (DIFC)'s 13F filing for Q2 2024, filed 14 Aug 2024.